SCHIZO AFFECTIVE DISORDER
Clinical trials for SCHIZO AFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZO AFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZO AFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tailored obesity drugs offer new hope for bipolar patients
Disease control Recruiting nowThis study aims to find the best weight-loss medication for people with bipolar disorder by matching drugs to specific obesity types (like 'hungry brain' or 'hungry gut'). About 100 adults aged 18-65 with bipolar or schizoaffective disorder and obesity will receive one of three F…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 02:17 UTC
-
Could an allergy drug help schizophrenia?
Symptom relief Recruiting nowThis study tests whether adding cromoglicate, a drug used for allergies, can improve symptoms in people with schizophrenia or schizoaffective disorder. About 160 adults aged 18-60 who are already on a stable antipsychotic medication will receive either cromoglicate or a placebo f…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Vishwajit Nimgaonkar, MD PhD • Aim: Symptom relief
Last updated May 26, 2026 02:21 UTC
-
New shock therapy aims to erase suicidal thoughts without memory loss
Symptom relief Recruiting nowThis study compares a new, lower-energy seizure therapy (LAP-ST) to standard electroconvulsive therapy (ECT) for quickly reducing suicidal thoughts in people with depression, bipolar disorder, or schizoaffective disorder. The goal is to see if the new treatment works as well or b…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE2, PHASE3 • Sponsor: Michigan State University • Aim: Symptom relief
Last updated May 19, 2026 12:01 UTC
-
New drug aims to quiet agitation in teens with mental illness
Symptom relief Recruiting nowThis study tests whether BXCL501 can safely reduce agitation in children aged 10-17 with schizophrenia or bipolar disorder. Participants receive either the drug or a placebo, and researchers measure changes in agitation using a standard rating scale. The trial is currently recrui…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE1 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC
-
Brain wave study seeks hidden clues to psychosis
Knowledge-focused Recruiting nowThis study looks at how the brain's earliest visual processing areas work in people with schizophrenia, bipolar disorder, or schizoaffective disorder. Researchers will use EEG (a non-invasive brain wave test) to measure electrical activity while participants view simple visual pa…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated May 26, 2026 02:28 UTC
-
Brain zapping study seeks to unravel hallucination mystery
Knowledge-focused Recruiting nowThis study uses a safe, noninvasive brain stimulation technique called TMS to learn how hallucinations happen in people with schizophrenia or schizoaffective disorder. Researchers will measure brain activity and symptom changes in 68 participants before and after TMS. The goal is…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC